Vanda Pharmaceuticals Inc (VNDA) — Capital Reinvestment Ratio
Latest as of March 2024:
0.00x
Vanda Pharmaceuticals Inc (VNDA) has a Capital Reinvestment Ratio of 0.00x as of March 2024, meaning it reinvests 0% of its operating cash flow ($7.57 Million) in capital expenditures ($7.00K). See free cash flow generation of Vanda Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$7.57 Million
USD
Capital Expenditures
$7.00K
USD
Data as of
Mar 2024
Most recent filing
Vanda Pharmaceuticals Inc Capital Reinvestment Ratio (2009–2023)
This chart tracks Vanda Pharmaceuticals Inc's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Vanda Pharmaceuticals Inc (2009–2023)
Year-by-year Capital Reinvestment Ratio for Vanda Pharmaceuticals Inc from 2009 to 2023. For live market cap and broader valuation context, see how much is Vanda Pharmaceuticals Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.03x | $12.80 Million | $383.00K | ▲ +40.9% |
| 2022 | 0.02x | $31.98 Million | $679.00K | ▲ +147.0% |
| 2021 | 0.01x | $64.21 Million | $552.00K | ▼ -75.2% |
| 2020 | 0.03x | $51.77 Million | $1.79 Million | ▲ +56.3% |
| 2019 | 0.02x | $45.95 Million | $1.02 Million | ▼ -97.4% |
| 2018 | 0.85x | $29.99 Million | $25.37 Million | ▲ +316.8% |
| 2015 | 0.20x | $12.45 Million | $2.53 Million | ▲ +186.4% |
| 2009 | 0.07x | $169.34 Million | $12.00 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow